Physiological and Pathological Factors Affecting Drug Delivery to the Brain by Nanoparticles
Abstract The prevalence of neurological/neurodegenerative diseases, such as Alzheimer's disease is known to be increasing due to an aging population and is anticipated to further grow in the decades ahead. The treatment of brain diseases is challenging partly due to the inaccessibility of thera...
Main Authors: | Yamir Islam, Andrew G. Leach, Jayden Smith, Stefano Pluchino, Christopher R. Coxon, Muttuswamy Sivakumaran, James Downing, Amos A. Fatokun, Meritxell Teixidò, Touraj Ehtezazi |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2021-06-01
|
Series: | Advanced Science |
Subjects: | |
Online Access: | https://doi.org/10.1002/advs.202002085 |
Similar Items
-
Brain–Immune Interactions and Neuroinflammation After Traumatic Brain Injury
by: Virginie Dinet, et al.
Published: (2019-11-01) -
Expression and Function of Organic Anion Transporting Polypeptides in the Human Brain: Physiological and Pharmacological Implications
by: Anima M. Schäfer, et al.
Published: (2021-06-01) -
Metabolite transport across the mammalian and insect brain diffusion barriers
by: Astrid Weiler, et al.
Published: (2017-11-01) -
Development of a Region-Specific Physiologically Based Pharmacokinetic Brain Model to Assess Hippocampus and Frontal Cortex Pharmacokinetics
by: Zaril Zakaria, et al.
Published: (2018-01-01) -
Pathological changes in the structures of the blood-brain barrier in acute cerebral circulatory disorders
by: S.І. Tertyshny, et al.
Published: (2012-04-01)